← Back

TidalSense

Cambridge, United Kingdom

$18.1M raisedFreshly fundedhealthtechdeeptechmedtech

Total Raised

$18.1M

Location

Cambridge, United Kingdom

Founded

2013

Team size

11-50

Links

About TidalSense

Cambridge-based startup developing AI-powered respiratory diagnostic technology.

What sets it apart

Its N-Tidal platform uses novel patented CO2 sensor technology plus AI to deliver regulated, non-spirometry respiratory diagnosis at the point of care in minutes.

Sectors

healthtechdeeptechmedtechAIdiagnostics

Business

Modelhardware

CustomerHealth systems, primary care clinicians, respiratory specialists, and diagnostics providers

Notable

  • N-Tidal Diagnose became the first non-spirometry AI diagnostic device cleared under EU MDR for COPD
  • Received CE-marked class 2a regulatory approval for N-Tidal Diagnose
  • Commissioned by Suffolk and North East Essex Integrated Care System
  • Raised €8.6 million in funding led by BGF and Downing

Explore the market

FAQ

What does TidalSense do?

Cambridge-based startup developing AI-powered respiratory diagnostic technology.

Where is TidalSense based?

TidalSense is based in Cambridge, United Kingdom, founded in 2013.

How much has TidalSense raised?

TidalSense has raised $18.1M in tracked funding.

Who has invested in TidalSense?

Investors in TidalSense include BGF, Downing, ARM, Asthma + Lung UK, Foresight Group and Foresight Ventures VCT.